Bionano Genomics Inc (BNGO) concluded trading on Wednesday at a closing price of $0.29, with 4.25 million shares of worth about $1.23 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -61.27% during that period and on October 23, 2024 the price saw a loss of about -4.19%. Currently the company’s common shares owned by public are about 86.00M shares, out of which, 85.45M shares are available for trading.
Stock saw a price change of -11.52% in past 5 days and over the past one month there was a price change of -29.81%. Year-to-date (YTD), BNGO shares are showing a performance of -84.40% which decreased to -80.08% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.30 but also hit the highest price of $2.27 during that period. The average intraday trading volume for Bionano Genomics Inc shares is 1.76 million. The stock is currently trading -23.67% below its 20-day simple moving average (SMA20), while that difference is down -32.07% for SMA50 and it goes to -64.07% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bionano Genomics Inc (NASDAQ: BNGO) currently have 86.00M outstanding shares and institutions hold larger chunk of about 11.55% of that.
The stock has a current market capitalization of $25.35M and its 3Y-monthly beta is at 2.32. It has posted earnings per share of -$5.01 in the same period. It has Quick Ratio of 1.11 while making debt-to-equity ratio of 0.34. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BNGO, volatility over the week remained 7.96% while standing at 9.51% over the month.
Stock’s fiscal year EPS is expected to rise by 83.44% while it is estimated to increase by 57.21% in next year.
Coverage by Scotiabank stated Bionano Genomics Inc (BNGO) stock as a Sector outperform in their note to investors on January 05, 2023, suggesting a price target of $4 for the stock. On December 12, 2022, BTIG Research Resumed their recommendations, while on July 18, 2022, Oppenheimer Resumed their ratings for the stock with a price target of $12. Stock get a Buy rating from BTIG Research on June 16, 2021.
